CVE-2024-36673
CVE-2024-36673 is a critical-severity vulnerability in Pharmacy/medical Store Point Of Sale System Project Pharmacy/medical Store Point Of Sale System with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.
Key facts
- Severity: Critical (CVSS 3.x base score 9.8)
- EPSS exploit prediction: 1% (41st percentile)
- Actively exploited: Not listed in CISA KEV
- EU (EUVD) id: EUVD-2024-36179
- Weakness: CWE-89
- Affected product: Pharmacy/medical Store Point Of Sale System Project Pharmacy/medical Store Point Of Sale System
- Published:
- Last modified:
Description
Sourcecodester Pharmacy/Medical Store Point of Sale System 1.0 is vulnerable SQL Injection via login.php. This vulnerability stems from inadequate validation of user inputs for the email and password parameters, allowing attackers to inject malicious SQL queries.
Frequently asked questions
- What is CVE-2024-36673?
- Sourcecodester Pharmacy/Medical Store Point of Sale System 1.0 is vulnerable SQL Injection via login.php. This vulnerability stems from inadequate validation of user inputs for the email and password parameters, allowing attackers to inject malicious SQL queries.
- How severe is CVE-2024-36673?
- CVE-2024-36673 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2024-36673 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2024-36673?
- CVE-2024-36673 affects Pharmacy/medical Store Point Of Sale System Project Pharmacy/medical Store Point Of Sale System. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2024-36673?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
- Does CVE-2024-36673 have an EU (EUVD) identifier?
- Yes. CVE-2024-36673 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-36179.
- When was CVE-2024-36673 published?
- CVE-2024-36673 was published on 2024-06-07 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:pharmacy\/medical_store_point_of_sale_system_project:pharmacy\/medical_store_point_of_sale_system:1.0:*:*:*:*:*:*:*
Other CWE-89 (SQL Injection) vulnerabilities
- CVE-2026-54350 — Critical (CVSS 10.0): Budibase is an open-source low-code platform. Prior to 3.39.12, an unauthenticated visitor of any published Budibase…
- CVE-2026-8054 — Critical (CVSS 10.0): Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in the Publish Audit API endpoints…
- CVE-2026-42287 — Critical (CVSS 10.0): Emlog is an open source website building system. Prior to version 2.6.11, direct SQL injection in article creation and…
- CVE-2026-3325 — Critical (CVSS 10.0): SQL injection (SQLi) in MegaCMS v12.0.0, specifically in the “id_territorio” parameter of the…
- CVE-2025-10878 — Critical (CVSS 10.0): A SQL injection vulnerability exists in the login functionality of Fikir Odalari AdminPando 1.0.1 before 2026-01-26.…
- CVE-2025-57792 — Critical (CVSS 10.0): Explorance Blue versions prior to 8.14.9 contain a SQL injection vulnerability caused by insufficient validation of…